Evidence map›Paper›PMID 42032137›Full record

ArticleNPJ precision oncology2026

CDNFE suggests FNDC3B and NECTIN4 as drivers of precancer progression via PI3K/AKT EMT.

Rui Qiao, Qingwei Zhang, Rabia Sultan, Wei Wang, Xinyan Zhang, Yizhen Qu, Wang Na, Xiuhong Fu, Feng Jiao, Peiluan Li

Abstract read
In one paragraph

Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rui Qiao *School of Mathematics and Statistics, Henan University of Science and Technology, Luoyang, China.
Qingwei Zhang *Department of Obstetrics and Gynecology, Luohe Central Hospital, Luohe, China.
Rabia Sultan *School of Life Sciences, Shanghai University, Shanghai, China.
Wei WangDepartment of Obstetrics and Gynecology, Luohe Central Hospital, Luohe, China.
Xinyan ZhangSchool of Life Sciences, Shanghai University, Shanghai, China.
Yizhen QuSchool of Mathematics and Statistics, Henan University of Science and Technology, Luoyang, China.
Wang NaYantai Penglai Traditional Chinese Medicine Hospital, Yantai, China.
Xiuhong FuDepartment of Obstetrics and Gynecology, Luohe Central Hospital, Luohe, China. fxh0430@sina.com.
Feng JiaoGuangzhou Center for Applied Mathematics, Guangzhou University, Guangzhou, China. jiaof@gzhu.edu.cn.
Peiluan LiSchool of Mathematics and Statistics, Henan University of Science and Technology, Luoyang, China. 9902639@haust.edu.cn.

Funding

Key Science and Technology Research Project of Henan Province No.242102310103, 252102520024, 252102240125National Natural Science Foundation of China T2541012Natural Science Foundation of Henan Province No.242300420242, 252300421985Open Project of Guangdong Provincial Key Laboratory of Mathematical and Neural Dynamical Systems DSNS2025011Open Project of Henan Province Key Laboratory of Fertility Protection and Eugenics SYLBHHYS2022-10
6 · The paper itself

Abstract

A tipping point signals the shift from a stable phase to a malignant state in cervical cancer progression. Identifying this transition is essential for early intervention, yet traditional biomarkers based on differential expression or undirected network measures often fail to capture it. Here, we introduce Causality-Directed Network Flow Entropy (CDNFE), a framework that quantifies entropy dynamics in directed regulatory networks to detect disease tipping points with superior sensitivity over expression-based methods. Applied to cervical cancer data which were derived from samples of different clinical stages collected from Luohe Central Hospital (single-cell, bulk transcriptome, simulations, and spatial transcriptomics), CDNFE consistently identified a precancerous tipping point and uncovered a biomarker module enriched for non-differentially expressed "dark genes." Within this module, FNDC3B and NECTIN4 emerged as central hubs, validated across multiple levels: (1) functionally essential in cervical cancer cell lines, (2) structurally important as driver nodes within regulatory networks, (3) mechanistically suggesting a potential link to PI3K/AKT signaling driven by epithelial-mesenchymal transition, and (4) spatially enriched in tumor regions in independent spatial transcriptomics sections. These findings establish CDNFE as a robust systems-level framework for tipping point detection and highlight FNDC3B and NECTIN4 as representative dark gene regulators of cervical cancer progression.

Identifiers

PMID42032137
PMCPMC13315249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.